Q9UBC3 (DNM3B_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 130.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: DNA (cytosine-5)-methyltransferase 3B Short name=Dnmt3b EC=2.1.1.37 Alternative name(s): DNA methyltransferase HsaIIIB Short name=DNA MTase HsaIIIB Short name=M.HsaIIIB | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 853 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. May preferentially methylates nucleosomal DNA within the nucleosome core region. May function as transcriptional co-repressor by associating with CBX4 and independently of DNA methylation. Seems to be involved in gene silencing By similarity. In association with DNMT1 and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Isoforms 4 and 5 are probably not functional due to the deletion of two conserved methyltransferase motifs. Function as transcriptional corepressor by associating with ZHX1. Ref.11 Ref.13 Ref.15 Ref.16 |
| Catalytic activity | S-adenosyl-L-methionine + DNA = S-adenosyl-L-homocysteine + DNA containing 5-methylcytosine. |
| Enzyme regulation | Activated by binding to the regulatory factor DNMT3L By similarity. |
| Subunit structure | Interacts with BAZ2A/TIP5, SUV39H1 and CBX4. Interacts with UHRF1 By similarity. Interacts with DNMT1 and DNMT3A, SETDB1, UBL1, UBE2I9 and ZHX1. Interacts with the PRC2/EED-EZH2 complex. Ref.8 Ref.9 Ref.10 Ref.11 Ref.13 |
| Subcellular location | |
| Tissue specificity | Ubiquitous; highly expressed in fetal liver, heart, kidney, placenta, and at lower levels in spleen, colon, brain, liver, small intestine, lung, peripheral blood mononuclear cells, and skeletal muscle. Isoform 1 is expressed in all tissues except brain, skeletal muscle and PBMC, 3 is ubiquitous, 4 is expressed in all tissues except brain, skeletal muscle, lung and prostate and 5 is detectable only in testis and at very low level in brain and prostate. |
| Domain | The PWWP domain is essential for targeting to pericentric heterochromatin. |
| Post-translational modification | Sumoylated. Ref.8 |
| Involvement in disease | Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860]: A rare disorder characterized by a variable immunodeficiency resulting in recurrent infections, facial anomalies, and branching of chromosomes 1, 9, and 16. Other variable symptoms include growth retardation, failure to thrive, and psychomotor retardation. Laboratory studies show limited hypomethylation of DNA in a small fraction of the genome in some, but not all, patients. |
| Sequence similarities | Belongs to the C5-methyltransferase family. Contains 1 ADD domain. Contains 1 GATA-type zinc finger. Contains 1 PHD-type zinc finger. Contains 1 PWWP domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| EED | O75530 | 4 | EBI-80125,EBI-923794 | |
| EZH2 | Q15910 | 6 | EBI-80125,EBI-530054 | |
| SUMO1 | P63165 | 4 | EBI-80125,EBI-80140 | |
| UBE2I | P63279 | 3 | EBI-80125,EBI-80168 | |
| ZHX1 | Q9UKY1 | 4 | EBI-6083193,EBI-347767 |
Alternative products
| This entry describes 8 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UBC3-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UBC3-2) The sequence of this isoform differs from the canonical sequence as follows: 356-375: Missing. | ||||||
| Isoform 3 (identifier: Q9UBC3-3) The sequence of this isoform differs from the canonical sequence as follows: 356-375: Missing. 745-807: Missing. | ||||||
| Isoform 4 (identifier: Q9UBC3-4) The sequence of this isoform differs from the canonical sequence as follows: 356-375: Missing. 744-744: R → S 745-853: Missing. | ||||||
| Isoform 5 (identifier: Q9UBC3-5) The sequence of this isoform differs from the canonical sequence as follows: 356-375: Missing. 768-853: LKKVQTITTK...APLKDYFACE → DLWLSCALHR...LRPSEGLLCM | ||||||
| Isoform 6 (identifier: Q9UBC3-6) The sequence of this isoform differs from the canonical sequence as follows: 1-1: M → MEPSPEPPSLESM 356-375: Missing. | ||||||
| Isoform 7 (identifier: Q9UBC3-7) The sequence of this isoform differs from the canonical sequence as follows: 69-144: Missing. 356-375: Missing. 744-806: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 8 (identifier: Q9UBC3-8) The sequence of this isoform differs from the canonical sequence as follows: 103-144: Missing. 356-375: Missing. 744-806: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 853 | 853 | DNA (cytosine-5)-methyltransferase 3B | PRO_0000088045 | |||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||
| Domain | 225 – 283 | 59 | PWWP | ||||||||||||||||||||||||||||||
| Domain | 423 – 555 | 133 | ADD | ||||||||||||||||||||||||||||||
| Zinc finger | 434 – 464 | 31 | GATA-type; atypical | ||||||||||||||||||||||||||||||
| Zinc finger | 475 – 531 | 57 | PHD-type; atypical | ||||||||||||||||||||||||||||||
| Region | 1 – 298 | 298 | Interaction with DNMT1 and DNMT3A | ||||||||||||||||||||||||||||||
| Region | 435 – 527 | 93 | Interaction with the PRC2/EED-EZH2 complex By similarity | ||||||||||||||||||||||||||||||
| Region | 582 – 586 | 5 | S-adenosyl-L-methionine binding By similarity | ||||||||||||||||||||||||||||||
| Region | 627 – 629 | 3 | S-adenosyl-L-methionine binding By similarity | ||||||||||||||||||||||||||||||
| Region | 832 – 834 | 3 | S-adenosyl-L-methionine binding By similarity | ||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||
| Active site | 651 | 1 | By similarity | ||||||||||||||||||||||||||||||
| Binding site | 605 | 1 | S-adenosyl-L-methionine By similarity | ||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||
| Modified residue | 82 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 96 | 1 | Phosphothreonine Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 100 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 110 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 136 | 1 | Phosphoserine Ref.17 Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 195 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 202 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||
| Modified residue | 209 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||
| Alternative sequence | 1 | 1 | M → MEPSPEPPSLESM in isoform 6. | VSP_005636 | |||||||||||||||||||||||||||||
| Alternative sequence | 69 – 144 | 76 | Missing in isoform 7. | VSP_045874 | |||||||||||||||||||||||||||||
| Alternative sequence | 103 – 144 | 42 | Missing in isoform 8. | VSP_045875 | |||||||||||||||||||||||||||||
| Alternative sequence | 356 – 375 | 20 | Missing in isoform 2, isoform 3, isoform 4, isoform 5, isoform 6, isoform 7 and isoform 8. | VSP_005637 | |||||||||||||||||||||||||||||
| Alternative sequence | 744 – 806 | 63 | Missing in isoform 7 and isoform 8. | VSP_045876 | |||||||||||||||||||||||||||||
| Alternative sequence | 744 | 1 | R → S in isoform 4. | VSP_005639 | |||||||||||||||||||||||||||||
| Alternative sequence | 745 – 853 | 109 | Missing in isoform 4. | VSP_005640 | |||||||||||||||||||||||||||||
| Alternative sequence | 745 – 807 | 63 | Missing in isoform 3. | VSP_005638 | |||||||||||||||||||||||||||||
| Alternative sequence | 768 – 853 | 86 | LKKVQ…YFACE → DLWLSCALHRRVQHGPWCPP EAAGKVLERACHPTPLRPSE GLLCM in isoform 5. | VSP_005641 | |||||||||||||||||||||||||||||
| Natural variant | 54 | 1 | R → P. Corresponds to variant rs17123590 [ dbSNP | Ensembl ]. | VAR_033885 | |||||||||||||||||||||||||||||
| Natural variant | 270 | 1 | S → P in ICF1. Ref.24 Corresponds to variant rs121908947 [ dbSNP | Ensembl ]. | VAR_022579 | |||||||||||||||||||||||||||||
| Natural variant | 585 | 1 | A → V in ICF1. Ref.23 Ref.24 | VAR_011506 | |||||||||||||||||||||||||||||
| Natural variant | 603 | 1 | A → T in ICF1. Ref.21 Ref.22 Ref.23 Ref.24 Corresponds to variant rs121908943 [ dbSNP | Ensembl ]. | VAR_011499 | |||||||||||||||||||||||||||||
| Natural variant | 606 | 1 | V → A in ICF1. Ref.23 Ref.24 Corresponds to variant rs146981624 [ dbSNP | Ensembl ]. | VAR_011507 | |||||||||||||||||||||||||||||
| Natural variant | 663 | 1 | G → S in ICF1. Ref.2 Ref.24 Corresponds to variant rs121908942 [ dbSNP | Ensembl ]. | VAR_011500 | |||||||||||||||||||||||||||||
| Natural variant | 664 | 1 | L → P in ICF1. Ref.24 | VAR_022580 | |||||||||||||||||||||||||||||
| Natural variant | 699 | 1 | V → G in ICF1. Ref.23 Ref.24 | VAR_011508 | |||||||||||||||||||||||||||||
| Natural variant | 726 | 1 | V → G in ICF1. Ref.2 Ref.22 Ref.23 Ref.24 Corresponds to variant rs121908941 [ dbSNP | Ensembl ]. | VAR_011501 | |||||||||||||||||||||||||||||
| Natural variant | 766 | 1 | A → P in ICF1. Ref.23 Ref.24 | VAR_011509 | |||||||||||||||||||||||||||||
| Natural variant | 806 | 1 | E → ESTP in ICF1. | VAR_011502 | |||||||||||||||||||||||||||||
| Natural variant | 814 | 1 | H → R in ICF1. Ref.23 Ref.24 | VAR_011510 | |||||||||||||||||||||||||||||
| Natural variant | 817 | 1 | D → G in ICF1. Ref.2 Ref.24 Corresponds to variant rs121908939 [ dbSNP | Ensembl ]. | VAR_011503 | |||||||||||||||||||||||||||||
| Natural variant | 818 | 1 | V → M in ICF1. Ref.2 Ref.23 Ref.24 Corresponds to variant rs121908940 [ dbSNP | Ensembl ]. | VAR_011504 | |||||||||||||||||||||||||||||
| Natural variant | 840 | 1 | R → Q in ICF1. Ref.24 Corresponds to variant rs121908946 [ dbSNP | Ensembl ]. | VAR_022581 | |||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||
| Sequence conflict | 575 | 1 | I → T in BAG61690. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 583 | 1 | G → D in BAG61753. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 655 | 1 | S → P in BAG61690. Ref.4 | ||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||
| Beta strand | 228 – 231 | 4 | |||||||||||||||||||||||||||||||
| Beta strand | 239 – 244 | 6 | |||||||||||||||||||||||||||||||
| Helix | 246 – 249 | 4 | |||||||||||||||||||||||||||||||
| Beta strand | 258 – 263 | 6 | |||||||||||||||||||||||||||||||
| Turn | 264 – 266 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 269 – 273 | 5 | |||||||||||||||||||||||||||||||
| Turn | 274 – 276 | 3 | |||||||||||||||||||||||||||||||
| Helix | 283 – 286 | 4 | |||||||||||||||||||||||||||||||
| Helix | 289 – 294 | 6 | |||||||||||||||||||||||||||||||
| Helix | 296 – 313 | 18 | |||||||||||||||||||||||||||||||
| Helix | 325 – 337 | 13 | |||||||||||||||||||||||||||||||
| Turn | 341 – 343 | 3 | |||||||||||||||||||||||||||||||
| Helix | 345 – 348 | 4 | |||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, expression and chromosome locations of the human DNMT3 gene family." Xie S., Wang Z., Okano M., Nogami M., Li Y., He W.-W., Okumura K., Li E. Gene 236:87-95(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3). Tissue: Fetal testis and Small intestine. |
| [2] | "Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene." Xu G.-L., Bestor T.H., Bourc'his D., Hsieh C.-L., Tommerup N., Bugge M., Hulten M., Qu X., Russo J.J., Viegas-Pequignot E. Nature 402:187-191(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), VARIANTS ICF1 SER-663; GLY-726; GLY-817 AND MET-818. Tissue: Testis. |
| [3] | "Cloning, expression and characterization of human DNMT3 genes." Ni J., Pradhan S., Roberts R.J. Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 8). Tissue: Brain. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors." Robertson K.D., Uzvolgyi E., Liang G., Talmadge C., Sumegi J., Gonzales F.A., Jones P.A. Nucleic Acids Res. 27:2291-2298(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 636-853 (ISOFORMS 1; 4 AND 5). Tissue: Testis. |
| [8] | "Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1." Kang E.S., Park C.W., Chung J.H. Biochem. Biophys. Res. Commun. 289:862-868(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH UBL1 AND UBE2I9, SUMOYLATION, SUBCELLULAR LOCATION. |
| [9] | "Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases." Kim G.-D., Ni J., Kelesoglu N., Roberts R.J., Pradhan S. EMBO J. 21:4183-4195(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DNMT1 AND DNMT3A, SUBCELLULAR LOCATION. |
| [10] | "The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells." Li H., Rauch T., Chen Z.-X., Szabo P.E., Riggs A.D., Pfeifer G.P. J. Biol. Chem. 281:19489-19500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SETDB1. |
| [11] | "The Polycomb group protein EZH2 directly controls DNA methylation." Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M., Esteller M., Di Croce L., de Launoit Y., Fuks F. Nature 439:871-874(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH THE PRC2/EED-EZH2 COMPLEX. |
| [12] | Erratum Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M., Esteller M., Di Croce L., de Launoit Y., Fuks F. Nature 446:824-824(2006) |
| [13] | "Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression." Kim S.H., Park J., Choi M.C., Kim H.P., Park J.H., Jung Y., Lee J.H., Oh D.Y., Im S.A., Bang Y.J., Kim T.Y. Biochem. Biophys. Res. Commun. 355:318-323(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH ZHX1. |
| [14] | "Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer." Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., Bergman Y., Simon I., Cedar H. Nat. Genet. 39:232-236(2007) [PubMed] [Europe PMC] [Abstract] Cited for: DE NOVO DNA METHYLATION OF TARGET GENES. |
| [15] | "DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation." Sun L., Huang L., Nguyen P., Bisht K.S., Bar-Sela G., Ho A.S., Bradbury C.M., Yu W., Cui H., Lee S., Trepel J.B., Feinberg A.P., Gius D. Cancer Res. 68:2726-2735(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [16] | "DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription." Kim S.-H., Park J., Choi M.-C., Park J.-H., Kim H.-P., Lee J.-H., Oh D.-Y., Im S.-A., Bang Y.-J., Kim T.-Y. Int. J. Biochem. Cell Biol. 40:2462-2471(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [17] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; THR-96; SER-100; SER-110; SER-136; SER-195; SER-202 AND SER-209, MASS SPECTROMETRY. |
| [19] | "Crystal structure of the PWWP domain of human DNA (cytosine-5-)-methyltransferase 3 beta." Structural genomics consortium (SGC) Submitted (MAR-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 206-355. |
| [20] | "Structural and histone binding ability characterizations of human PWWP domains." Wu H., Zeng H., Lam R., Tempel W., Amaya M.F., Xu C., Dombrovski L., Qiu W., Wang Y., Min J. PLoS ONE 6:E18919-E18919(2011) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) OF 380-509. |
| [21] | "DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development." Okano M., Bell D.W., Haber D.A., Li E. Cell 99:247-257(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ICF1 THR-603 AND SER-THR-PRO-806 INS. |
| [22] | "The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome." Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M.R., Gartler S.M. Proc. Natl. Acad. Sci. U.S.A. 96:14412-14417(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ICF1 THR-603; GLY-726 AND SER-THR-PRO-806 INS. |
| [23] | "Genetic variation in ICF syndrome: evidence for genetic heterogeneity." Wijmenga C., Hansen R.S., Gimelli G., Bjoerck E.J., Davies E.G., Valentine D., Belohradsky B.H., van Dongen J.J., Smeets D.F.C.M., van den Heuvel L.P.W.J., Luyten J.A.F.M., Strengman E., Weemaes C.M.R., Pearson P.L. Hum. Mutat. 16:509-517(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ICF1 VAL-585; THR-603; ALA-606; GLY-699; GLY-726; PRO-766; ARG-814 AND MET-818. |
| [24] | "DNMT3B mutations and DNA methylation defect define two types of ICF syndrome." Jiang Y.L., Rigolet M., Bourc'his D., Nigon F., Bokesoy I., Fryns J.-P., Hulten M., Jonveaux P., Maraschio P., Megarbane A., Moncla A., Viegas-Pequignot E. Hum. Mutat. 25:56-63(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ICF1 PRO-270; VAL-585; THR-603; ALA-606; SER-663; PRO-664; GLY-699; GLY-726; PRO-766; ARG-814; GLY-817; MET-818 AND GLN-840. |
| + | Additional computationally mapped references. |
Web resources
| DNMT3Bbase DNMT3B mutation db |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF156487 mRNA. Translation: AAD53062.1. AF156488 mRNA. Translation: AAD53063.1. AF176228 mRNA. Translation: AAF04015.1. AF331857 mRNA. Translation: AAL57040.1. AK299821 mRNA. Translation: BAG61690.1. AK299915 mRNA. Translation: BAG61753.1. AL035071 Genomic DNA. Translation: CAB53069.1. AL035071 Genomic DNA. Translation: CAB53070.1. AL035071 Genomic DNA. Translation: CAB53071.1. AL035071 Genomic DNA. Translation: CAM27373.1. CH471077 Genomic DNA. Translation: EAW76351.1. CH471077 Genomic DNA. Translation: EAW76352.1. CH471077 Genomic DNA. Translation: EAW76353.1. CH471077 Genomic DNA. Translation: EAW76354.1. CH471077 Genomic DNA. Translation: EAW76356.1. AF129267 mRNA. Translation: AAD31432.1. AF129268 mRNA. Translation: AAD31433.1. AF129269 mRNA. Translation: AAD31434.1. | ||||||||||||||||||
| IPI | IPI00012593. IPI00180702. IPI00218357. IPI00218358. IPI00218359. IPI00218360. IPI00908348. IPI00942456. | ||||||||||||||||||
| RefSeq | NP_001193984.1. NM_001207055.1. NP_001193985.1. NM_001207056.1. NP_008823.1. NM_006892.3. NP_787044.1. NM_175848.1. NP_787045.1. NM_175849.1. NP_787046.1. NM_175850.2. | ||||||||||||||||||
| UniGene | Hs.713611. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q9UBC3. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-30000N. | ||||||||||||||||||
| IntAct | Q9UBC3. 10 interactions. | ||||||||||||||||||
| MINT | MINT-2820816. | ||||||||||||||||||
| STRING | 9606.ENSP00000328547. | ||||||||||||||||||
Protein family/group databases | |||||||||||||||||||
| REBASE | 4120. M.HsaDnmt3B. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q9UBC3. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 17375667. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q9UBC3. | ||||||||||||||||||
| PRIDE | Q9UBC3. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 1789. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000201963; ENSP00000201963; ENSG00000088305. ENST00000328111; ENSP00000328547; ENSG00000088305. ENST00000344505; ENSP00000345105; ENSG00000088305. ENST00000348286; ENSP00000337764; ENSG00000088305. ENST00000353855; ENSP00000313397; ENSG00000088305. ENST00000443239; ENSP00000403169; ENSG00000088305. ENST00000456297; ENSP00000412305; ENSG00000088305. | ||||||||||||||||||
| GeneID | 1789. | ||||||||||||||||||
| KEGG | hsa:1789. | ||||||||||||||||||
| UCSC | uc002wyc.3. human. uc002wyd.3. human. uc002wye.3. human. uc002wyf.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 1789. | ||||||||||||||||||
| GeneCards | GC20P031350. | ||||||||||||||||||
| HGNC | HGNC:2979. DNMT3B. | ||||||||||||||||||
| HPA | HPA001595. | ||||||||||||||||||
| MIM | 242860. phenotype. 602900. gene. | ||||||||||||||||||
| neXtProt | NX_Q9UBC3. | ||||||||||||||||||
| Orphanet | 2268. ICF syndrome. | ||||||||||||||||||
| PharmGKB | PA27446. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG70699. | ||||||||||||||||||
| HOVERGEN | HBG051381. | ||||||||||||||||||
| InParanoid | Q9UBC3. | ||||||||||||||||||
| KO | K00558. | ||||||||||||||||||
| OMA | RRKDWNV. | ||||||||||||||||||
| OrthoDB | EOG4CVG68. | ||||||||||||||||||
| PhylomeDB | Q9UBC3. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q9UBC3. | ||||||||||||||||||
| Bgee | Q9UBC3. | ||||||||||||||||||
| CleanEx | HS_DNMT3B. | ||||||||||||||||||
| Genevestigator | Q9UBC3. | ||||||||||||||||||
| GermOnline | ENSG00000088305. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR025766. ADD. IPR018117. C5_DNA_meth_AS. IPR001525. C5_MeTfrase. IPR025811. C5_MeTrfase_3. IPR000313. PWWP. IPR011011. Znf_FYVE_PHD. [Graphical view] | ||||||||||||||||||
| Pfam | PF00145. DNA_methylase. 1 hit. PF00855. PWWP. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00293. PWWP. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF57903. FYVE_PHD_ZnF. 1 hit. | ||||||||||||||||||
| PROSITE | PS51533. ADD. 1 hit. PS00094. C5_MTASE_1. 1 hit. PS00095. C5_MTASE_2. False negative. PS50812. PWWP. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| BindingDB | Q9UBC3. | ||||||||||||||||||
| ChEMBL | CHEMBL6095. | ||||||||||||||||||
| EvolutionaryTrace | Q9UBC3. | ||||||||||||||||||
| GenomeRNAi | 1789. | ||||||||||||||||||
| NextBio | 7289. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | DNM3B_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UBC3 Secondary accession number(s): A2A2E2 Q9Y5S0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
